Loading…
Decreased serum amyloid β 1–42 autoantibody levels in Alzheimer’s disease, determined by a newly developed immuno-precipitation assay with radiolabeled amyloid β 1–42 peptide
Brettschneider, Sylvia, Morgenthaler, Nils G., Teipel, Stefan J., Fischer-Schulz, Christina, Bürger, Katharina, Dodel, Richard, Du, Yansheng, Möller, Hans-Jürgen, Bergmann, Andreas, Hampel, Harald
Published in Biological psychiatry (1969) (2005)
Published in Biological psychiatry (1969) (2005)
Get full text
Journal Article
Loading…
MicroRNA-455-3p as a potential peripheral biomarker for Alzheimer’s disease
Kumar, Subodh, Vijayan, Murali, Reddy, P. Hemachandra
Published in Human molecular genetics (01.10.2017)
Published in Human molecular genetics (01.10.2017)
Get full text
Journal Article
Loading…
Loading…
Epilepsy, β amyloid and D1 dopamine receptors: a possible pathogenetic link?
Costa, Cinzia, Parnetti, Lucilla, D’Amelio, Marcello, Tozzi, Alessandro, Tantucci, Michela, Romigi, Andrea, Siliquini, Sabrina, Cavallucci, Virve, Di Filippo, Massimiliano, Mazzocchetti, Petra, Liguori, Claudio, Nobili, Annalisa, Eusebi, Paolo, Mercuri, Nicola B, Calabresi, Paolo
Published in Neurobiology of aging (2016)
Published in Neurobiology of aging (2016)
Get full text
Journal Article